Cargando…
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity
DNA methylation is an epigenetic modification of the mammalian genome that occurs predominantly at cytosine residues of the CpG dinucleotide. Following formaldehyde activation, pixantrone alkylates DNA and particularly favours the CpG motif. Aberrations in CpG methylation patterns are a feature of m...
Autores principales: | Evison, Benny J., Bilardi, Rebecca A., Chiu, Francis C. K., Pezzoni, Gabriella, Phillips, Don R., Cutts, Suzanne M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770666/ https://www.ncbi.nlm.nih.gov/pubmed/19720735 http://dx.doi.org/10.1093/nar/gkp700 |
Ejemplares similares
-
The impact of intragenic CpG content on gene expression
por: Bauer, Asli Petra, et al.
Publicado: (2010) -
Cytosine methylation at CpCpG sites triggers accumulation of non-CpG methylation in gene bodies
por: Zabet, Nicolae Radu, et al.
Publicado: (2017) -
No evidence of extensive non-CpG methylation in mtDNA
por: Guitton, Romain, et al.
Publicado: (2022) -
CpG domains downstream of TSSs promote high levels of gene expression
por: Krinner, Simone, et al.
Publicado: (2014) -
Implications of CpG islands on chromosomal architectures and modes of global gene regulation
por: Beck, Samuel, et al.
Publicado: (2018)